During the past years, the pharmaceutical industry has been facing several obstacles caused by the crisis and the pressure from governmental bodies and patients. Industry sales have firmly and significantly increased due to the the development of new and emerging drugs.The emphasis was made on well-planned market access strategy, which is essential to accomplish cost -saving purposes. Participants will gain insights into HTA regulations and other challenges associated to different geographical area.
Global Leading Conferencesis committed to engage with pharmaceutical companies, payers and hospital representative to debate methods and principles that will enable the development of pricing and reimbursement processes that mirror the value of products and future innovations.
Comments